injection of a murine Kras-driven pancreatic cancer cell line (mt4-2D)34 in C57BL6 syngeneic mice (Fig. 4b and Supplementary Fig. 6B), showing thatthe antibody is effective also in the presence of a fully developed immunesystem. Here, KRAS is linked to pancreatic neoplasm.